Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | BCL9 | O00512 | 1/20 | 0.43 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9710536 | 0.85 | ALDH1A1 (0.57) | MAPTALDH1A1LMNAMEN1KMT2A | |
| SCHEMBL9710538 | 0.83 | MAPT (0.55) | MAPTALDH1A1LMNAMEN1KMT2A | |
| SCHEMBL10996751 | 0.81 | MAPT (0.53) | MAPTALDH1A1LMNAMEN1KMT2A | |
| SCHEMBL4435225 | 0.80 | MAPT (0.52) | MAPTALDH1A1LMNAMEN1KMT2A | |
| SCHEMBL521069 | 0.79 | MAPT (0.57) | MAPTALDH1A1LMNAMEN1KMT2A | |
| SCHEMBL9969599 | 0.79 | CYP2C19 (0.53) | MAPTALDH1A1MEN1KMT2AHTT | |
| SCHEMBL9976430 | 0.78 | ALDH1A1 (0.55) | MAPTALDH1A1HTTSMN1; SMN2GAA | |
| SCHEMBL6261030 | 0.77 | TSHR (0.53) | ALDH1A1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL11794354 | 0.77 | ALDH1A1 (0.49) | MAPTALDH1A1LMNAMEN1KMT2A | |
| SCHEMBL31154474 | 0.77 | LMNA (0.52) | MAPTALDH1A1LMNAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8101655-B2 | Fluorescent dyes and complexes | SMITH GERALD ARTHUR (GB) | 2012-01-24 | — | — | US | disclosed |
| US-8101655-B2 | Fluorescent dyes and complexes | SMITH GERALD ARTHUR (GB) | 2012-01-24 | — | — | US | disclosed |
| US-20100256399-A1 | FLUORESCENT DYES AND COMPLEXES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2010-10-07 | — | — | US | disclosed |
| US-20100256399-A1 | FLUORESCENT DYES AND COMPLEXES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2010-10-07 | — | — | US | disclosed |
| US-7674918-B2 | Fluorescent dyes and complexes | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2010-03-09 | — | — | US | disclosed |
| US-7674918-B2 | Fluorescent dyes and complexes | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2010-03-09 | — | — | US | disclosed |
| US-20070238884-A1 | Fluorescent Dyes and Complexes | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2007-10-11 | — | — | US | disclosed |
| US-20070238884-A1 | Fluorescent Dyes and Complexes | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2007-10-11 | — | — | US | disclosed |
| US-20070238884-A1 | Fluorescent Dyes and Complexes | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2007-10-11 | — | — | US | disclosed |
| EP-1740947-A2 | FLUORESCENT DYES AND COMPLEXES | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) | 2007-01-10 | — | — | EP | disclosed |
| WO-2005098437-A2 | FLUORESCENT DYES AND COMPLEXES | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LTD (GB) | 2005-10-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070238884-A1 | Fluorescent Dyes and Complexes | F12, PYM1, ANXA6 | MAPT 3961/4885ALDH1A1 1039/4885LMNA 461/4885 |
| US-20100256399-A1 | FLUORESCENT DYES AND COMPLEXES | F12, ANXA6, PYM1 | MAPT 3957/4885ALDH1A1 1468/4885LMNA 409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.